Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-36,000
Closed -$2.5M – 6913
2017
Q1
$2.5M Sell
36,000
-50,000
-58% -$3.46M ﹤0.01% 1871
2016
Q4
$5.8M Sell
86,000
-6,300
-7% -$427K 0.01% 1301
2016
Q3
$6.75M Sell
92,300
-3,100
-3% -$219K 0.01% 1084
2016
Q2
$6.56M Buy
95,400
+42,300
+80% +$2.96M 0.01% 1125
2016
Q1
$3.77M Buy
+53,100
New +$3.59M 0.01% 1397

Other funds holding STE

Barclays's STE Position: Q3 2026 in Review

Barclays increased its Steris (STE) stake by 20% in Q3 2026, buying an estimated $6.28M and bringing the position to 169,856 shares worth $35.7M. The position accounts for 0.01% of the portfolio, ranked #940.

Barclays first reported a position in STE in Q2 2013 and has held it in 53 quarters since. The position peaked at $46.3M in Q3 2025. 683 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • Barclays held 169,856 shares of Steris worth $35.7M as of Q3 2026.
  • Barclays bought 28,274 Steris shares in Q3 2026, an estimated $6.28M.
  • Steris made up 0.01% of Barclays's portfolio in Q3 2026, its #940 holding.
  • Barclays first reported a position in Steris in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Steris position peaked at $46.3M in Q3 2025.
  • 683 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.